U.S. Airlines Stock News

In the past week, Redwire Corporation announced a follow-on equity offering of US$250 million and reported third-quarter results with sales of US$103.43 million but a widened net loss of US$41.15 million compared to the previous year. The company lowered its full-year revenue guidance to US$320 million–US$340 million, citing delayed U.S. government orders resulting from an ongoing government shutdown, which has influenced the timing of anticipated contract awards. We'll examine how Redwire's...

On November 4, 2025, Aura Minerals Inc. announced its Board of Directors approved a US$0.48 per share dividend, about US$40.1 million total, scheduled for payment on November 21 to shareholders of record as of November 17. This dividend move comes alongside Aura Minerals increasing its stake in Altamira Gold Corp. to approximately 18.22%, signaling investment in exploration opportunities. We'll explore how Aura's sizable dividend declaration adds a compelling income-focused angle to its...

CBIZ (CBZ) has caught the attention of many investors recently as its stock has seen some movement over the past week. Curious observers are comparing recent performance with longer-term trends to gauge what might be next for the company. See our latest analysis for CBIZ. CBIZ’s share price has been notably volatile, with a 1.28% bump in the past day but still down 19.41% over the last three months, reflecting shifting investor sentiment. While short-term share price momentum has faded,...

Earlier in November 2025, Alaska Air Group faced recurring daily flight cancellations as a result of a Federal Aviation Administration directive prompted by air traffic control shortages during a government shutdown, affecting major airports including Seattle-Tacoma International Airport. This disruption highlights how external regulatory and staffing factors can swiftly impact airline operations and service reliability, regardless of internal advancements or recent mergers. We'll explore...

Travere Therapeutics recently presented new Phase 3 DUPLEX Study data at ASN Kidney Week 2025, showing that FILSPARI® (sparsentan) significantly reduced proteinuria and was linked to a lower risk of kidney failure in patients with focal segmental glomerulosclerosis (FSGS) compared to the standard treatment, irbesartan. An important insight from the announcement is that FILSPARI achieved higher rates of partial and complete remission with a favorable safety profile, positioning it as a...

Earlier this week, Sonoco Products announced a major consolidation of its Metal Packaging and Rigid Paper Containers businesses into two new geographic divisions, alongside senior leadership appointments for its Consumer Packaging operations in EMEA/APAC and the Americas. This realignment signals a sharpened focus on regional management and operational integration, with experienced leaders stepping into pivotal roles to oversee growth and efficiency across these core packaging...

Vicor (VICR) recently posted a standout Q3 earnings report, with profits outpacing estimates thanks to booming demand for its high-density power systems in AI data centers. The results sent the stock price up over 55% in a single week. See our latest analysis for Vicor. Vicor’s rapid ascent has been fueled by a blockbuster Q3 earnings result, sending its share price up an incredible 90.7% over the past month and cementing a year-to-date share price return of 92%. While the total shareholder...

On November 7, 2025, Viasat, Inc. reported second-quarter financial results, highlighting a sharp reduction in net loss to US$61.44 million from US$137.58 million a year earlier and slight revenue growth to US$1.14 billion. The company announced a record US$1.2 billion backlog in its Defense and Advanced Technologies segment, underscoring strong demand and supportive prospects for future revenue generation. We'll explore what Viasat's improved financial performance and strengthening defense...

Valaris (VAL) just posted third-quarter earnings that saw net income climb substantially compared to a year ago, even as revenue slipped. At the same time, the company wrapped up a major phase of its share repurchase program. See our latest analysis for Valaris. Valaris has been on a roll lately, gaining positive momentum after its robust third-quarter results and high-profile share buybacks. Investors have taken notice, with the share price up 17.7% over the past month and 29.4%...

HP's stock recently declined even as broader markets rose, attracting attention with its next earnings report set for November 25, 2025. This heightened interest reflects investor focus on slightly lower earnings expectations and a recent sell rating from Zacks Rank. We'll explore how analyst concerns about modestly reduced earnings estimates may shape HP's forward-looking investment narrative. Rare earth metals are the new gold rush. Find out which 37 stocks are leading the charge.HP...

10x Genomics recently reported third quarter results showing a slightly lower year-over-year revenue of US$149 million and reduced net loss, and also announced the launch of its next-generation, automation-compatible Flex assay for scalable single cell analysis. The company's guidance for fourth quarter 2025 points to a 6% revenue decline year-over-year but sequential growth, highlighting both persistent market headwinds and renewed product innovation. With the launch of an...

JetBlue Airways has announced the upcoming launch of nonstop service to Florida's Emerald Coast, with flights from Boston and New York to Destin-Fort Walton Beach Airport beginning March 5, 2026, as part of an expansion adding more than 30 new Florida routes this year. This move strengthens JetBlue's position in the competitive Northeast-Florida corridor and extends its reach into one of Florida’s fastest-growing leisure destinations, reflecting a broader commitment to East Coast leisure...

Skyward Specialty Insurance Group (SKWD) saw its stock move slightly today, giving investors another look at how the company is managing through the current market environment. Recent performance trends are shaping expectations on where SKWD could head next. See our latest analysis for Skyward Specialty Insurance Group. Skyward Specialty Insurance Group’s stock has shown modest momentum lately, with a recent pop helping offset some of this year’s earlier declines. Despite a robust 2023 for...

In its third-quarter 2025 results announced earlier this month, Pinterest reported revenue of US$1.05 billion and net income of US$92.11 million, both rising from the prior year but missing analyst estimates, with management also citing tariffs' impact on ad spending as a reason for cautious fourth-quarter guidance. Despite these pressures, Pinterest highlighted robust international user growth and progress in rolling out new AI-powered shopping tools, aiming to deepen engagement and expand...

Danaher (DHR) stock is on investors’ radar following recent performance data that highlights both short-term gains and long-term challenges. With the share price edging up in the past month, some are taking a closer look at the company’s earnings growth and valuation. See our latest analysis for Danaher. After a choppy start to the year, Danaher’s share price has rallied over the last month with a 6.6% gain, suggesting some investors are warming up to its story even as the total shareholder...

Burford Capital (NYSE:BUR) released its third-quarter earnings, revealing that revenue fell sharply compared to last year and the company swung to a net loss for the period. This earnings miss is weighing on investor sentiment. See our latest analysis for Burford Capital. Shares of Burford Capital have been under pressure in recent months, with a 30-day share price return of -18.78% and a much deeper slide of -35.19% over the past quarter. The latest earnings disappointment appears to have...

Kodiak Sciences (KOD) caught investors’ attention after it reported positive follow-up data from the APEX trial of KSI-101. The results showed ongoing gains in visual acuity and durable retinal dryness in patients. The Phase 3 results also highlighted rapid onset and favorable tolerability, according to recent clinical updates. See our latest analysis for Kodiak Sciences. Kodiak Sciences’ rapid share price run, soaring 127.7% over the past quarter and 65.4% in the last month, has attracted...

Ever wondered if Molina Healthcare’s steeply discounted stock is actually a bargain hiding in plain sight? Let’s dive into what matters most for value-focused investors like you. After a stretch of significant declines, Molina Healthcare is down nearly 26% this month and over 50% year-to-date. This could signal a shift in the market’s take on its prospects or risk profile. Recent headlines have spotlighted Molina’s competitive positioning amid shifting healthcare regulations and several new...

Smurfit Westrock plc reported third quarter 2025 earnings, showing higher sales of US$8.00 billion and net income of US$246 million, and approved a quarterly dividend of US$0.4308 per share for payment in December to shareholders as of November 14. An increase in impairment charges to US$58 million in the quarter, up from US$2 million a year earlier, reflected ongoing business adjustments during a period of profitability improvement. We'll examine how the company's improved profitability...

Allstate (ALL) just posted a jump in both revenue and net income for the third quarter, with earnings per share climbing sharply from a year ago. The numbers are already drawing increased attention from investors and analysts alike. See our latest analysis for Allstate. Allstate’s strong earnings and recent share buybacks have clearly put the spotlight on the company, with analysts expressing renewed confidence. After this upbeat quarter, the share price has climbed 6.2% over the past week...

ICL Group (NYSE:ICL) is making some important changes after announcing the discontinuation of its planned lithium iron phosphate cathode projects in both the US and Spain. This move comes as government funding was withdrawn, and shifting dynamics in the electric vehicle market have influenced the decision. See our latest analysis for ICL Group. Even with ICL’s major strategic pivot and recent moves around its lithium iron phosphate projects, the stock has shown some resilience. While last...

RPC, Inc. recently reported third quarter 2025 earnings, revealing US$447.1 million in sales, a year-over-year increase, but a decrease in net income to US$12.96 million compared to US$18.8 million a year earlier. While sales growth was strong, the decline in profitability stands out, as it signals higher operating costs or margin pressures despite revenue gains. We'll examine how RPC's latest earnings, marked by higher sales but lower profits, reshape the company's investment...

Bausch Health Companies Inc. reported results for the third quarter ended September 30, 2025, showing revenue of US$2.68 billion and net income of US$179 million, both improved compared to the previous year. This shift from a net loss to net profitability indicates that operational improvements have translated into stronger bottom-line performance for the company. We'll explore how this turnaround in profitability could influence the company's investment narrative and outlook for future...

ManpowerGroup announced a partnership with Maricopa Community Colleges in Arizona to deliver specialized training and workforce development pathways targeting skilled labor shortages in the semiconductor and advanced manufacturing sectors. This collaboration aligns educational resources directly with employer needs, offering hands-on programs in AI, engineering, and technician roles to accelerate pathways into high-demand careers. We'll explore how this workforce development initiative could...